Kinesins comprise a superfamily of motor proteins that impact a wide array of cellular functions by coupling ATP hydrolysis to the regulated and targeted movement of specific intracellular cargo along microtubule filaments. Kinesins have been functionally linked to various biological phenomena, including, but not limited to, cargo-containing vesicle transport, mitotic spindle formation, chromosome segregation, midbody formation, and cytokinesis completion (16, 22) . All kinesins contain a highly conserved motor domain, within which resides the globular catalytic core that contains both microtubule and nucleotide binding sites that function together to generate the microtubule-stimulated ATPase activity (26) . In addition, the motor domain contains a highly conserved neck region (adjacent to the catalytic core) that can be subdivided into a neck linker and a neck coiled-coil (CC) region (23) . The neck linker serves to determine motor directionality (3) , and the neck CC can facilitate oligomer formation (18, 25) . The kinesin superfamily has been subdivided into 14 kinesin families (14) and can be further defined by the position of the motor domain at the N terminus (N type), C terminus (C type), or internal region (I type) (23) .
KIF14 is a mammalian kinesin classified as an N-type, kinesin-3 family member based upon phylogenetic sequence analysis of its presumptive motor domain (16, 19) . Our interest in KIF14 was piqued by the observation that elevated KIF14 expression is associated with poor-prognosis breast cancer (28). However, due to the limited functional annotation for KIF14 and its Drosophila orthologs, it is difficult to speculate on how KIF14 may contribute to breast cancer prognosis. Separate studies characterizing KLP38B, which is the KIF14 ortholog in Drosophila melanogaster, ascribed different functions to this kinesin. One study reported a role for KLP38B in chromosome segregation (17) , while another reported a role in cytokinesis (21) . In addition, the silencing of KIF14 in human cells by using endoribonuclease-prepared short interfering RNA (esiRNA) was reported to disturb chromosome congression and alignment, resulting in a prolonged delay at the metaphase-to-anaphase transition (33) .
In this report, we have characterized the mitotic expression, subcellular localization, and function of human KIF14. We establish that the KIF14 motor domain exhibits microtubuledependent ATPase activity and that KIF14 manifests the elevated mitotic expression and subcellular localization properties of a mitotic kinesin. In addition, siRNA-mediated silencing of KIF14 produced distinct phenotypes that could be linked to siRNA efficacy. Strong silencing of KIF14 prevented midbody cleavage, resulting in the formation of multinucleated cells. Less efficacious KIF14 siRNAs were found to elicit apoptosis of cells following entry into mitosis, during an attempt at cytokinesis, after binucleation due to cytokinesis failure, or after completion of cell division. Therefore, the data demonstrate that the silencing of KIF14 generates a multitude of mitotic phenotypes in which the efficacy of KIF14 silencing dictates the stage at which cell cycle progression is disrupted.
MATERIALS AND METHODS
Antibodies. Antibodies used for immunofluorescence are as follows: polyclonal anti-KIF14 antibody (Abcam, Inc.; ab3746) and monoclonal anti-alphatubulin antibody (Sigma; clone DM1A0). KIF14 was detected using Alexa Fluor 488 antibody (Invitrogen). Alpha tubulin was detected using Alexa Fluor 594 (Invitrogen) goat anti-mouse immunoglobulin G antibody.
Cell culture and transfections. HeLa-S3, HCT116, and HEK-293T cells were cultured in Dulbecco's modified Eagle's medium supplemented with 10% fetal bovine serum (Invitrogen) at 37°C. For siRNA transfections, cells were seeded in six-well (9.60 cm 2 ) culture dishes at a densities of 60,000 to 90,000 cells/well in 2 ml serum containing growth medium. Twenty-four hours after seeding, cells were transfected with 100 pmol of siRNA using Oligofectamine (Invitrogen) transfection reagent according to the manufacturer's protocol. Cells were incubated with transfection complexes under normal growth conditions until collection for analysis at specific time points posttransfection. All siRNA duplexes (Table 1) were purchased from Dharmacon (Lafayette, CO). Plasmid transfections of HEK-293T cells were performed on cells plated at 2 ϫ 10 4 cells per well in an eight-well chamber slide (Lab-Tek) and cultured overnight in 10% fetal bovine serum (Invitrogen). Cells were transfected the following day with 1 g plasmid DNA per well using TransIT 293 reagent (Mirus) in Opti-MEM medium (Invitrogen) according to the manufacturer's protocol and incubated overnight. The colony-forming capacity of siRNA-transfected HeLa-S3 cells was evaluated by plating cells at 100, 500, and 1,000 cells per well 48 h posttransfection followed by 2 weeks of uninterrupted culture before staining with crystal violet.
EGFP-tagged KIF14 (KIF14-EGFP) cloning.
The KIF14 open reading frame was PCR amplified from cDNA clone KIAA0042 (purchased from Kazusa DNA Research Institute) by using the following primers: KIF14-forward (5Ј-CTAGA AACCGTCCGGAATGTCATTACACAGTACTCAT-3Ј) and KIF14-reverse (5Ј-CTAGAAACGCGGATCCCACCCACTGAATCCTACTGG-3Ј). The PCR product was restriction digested and ligated into BspE1/BamHI-digested enhanced green fluorescent protein (EGFP) fusion vector pEGFP-C1 (BD Biosciences).
Immunoblot analysis of KIF14 expression. Transfected cells were trypsinized, collected by centrifugation (5 min at 300 ϫ g), and washed with phosphatebuffered saline. Cell pellets were resuspended in lysis buffer (20 mM Tris HCl [pH 7.6], 150 mM NaCl, 1 mM EDTA, 1% Triton X-100) containing 1ϫ protease inhibitor mix (Roche Complete) and incubated for 10 min on ice. Following centrifugation (10 min at 10,000 ϫ g), the supernatant was collected and the protein concentration was determined by using the Bio-Rad DC protein assay kit. Equivalent protein (25 g/sample) was resolved by sodium dodecyl sulfatepolyacrylamide gel electrophoresis (SDS-PAGE) on Bio-Rad ready gels (7.5% acrylamide or 4 to 15% acrylamide gradient). Proteins were transferred to a nitrocellulose membrane and blocked in TBST buffer (150 mM NaCl, 10 mM Tris-HCl [pH 7.6], 0.1% Tween 20) containing 5% nonfat dry milk (blocking buffer) for 30 min at room temperature. The membrane was then incubated with anti-KIF14 antibody (Abcam, Inc.; ab3746) diluted 1:1,000 in blocking buffer for 90 min at room temperature. After three washes in TBST, the membrane was incubated with horseradish peroxidase-conjugated goat anti-rabbit immunoglobulin G antibody (Zymed) diluted 1:10,000 in blocking buffer for 45 min at room temperature. Following three washes in TBST, the membrane was incubated in chemiluminescence detection reagents (ECL Plus, Amersham) and the image was captured using a charge-coupled device camera (Kodak Image Station 440CF).
Immunofluorescence microscopy. HeLa-S3 and 293T cells cultured on glass chamber well slides were fixed and permeabilized as described previously (12) for 15 min in immunohistochemical buffer. Following fixation, cells were washed with TBST and incubated with primary antibody for 90 min at 37°C. Cells were washed in TBST prior to secondary antibody addition and incubation at room temperature for 1 h followed by washes in TBST supplemented with 10 g/ml Hoechst in order to stain DNA. Samples were mounted with Fluoromount G (Southern Biotech) and visualized directly on a DeltaVision (version 3.5) deconvolution microscope (Applied Precision, Inc.) or an InCell Analyzer 1000 (GE Healthcare) by using DAPI (4Ј,6Ј-diamidino-2-phenylindole), fluorescein isothiocyanate, and rhodamine-Texas Red-phycoerythrin filter sets for blue, green, and red, respectively.
Time-lapse microscopy. Live cells were monitored in eight-well coverslip bottom chamber slides beginning at 20 or 40 h posttransfection via time-lapse image capture using n a DeltaVision version 3.5 deconvolution microscope (Applied Precision, Inc.). The microscope was fitted with a humidified 37°C/5% CO 2 incubation chamber (Solent Scientific) to maintain a suitable environment for sustained image collection. Bright-field images of 1,024 by 1,024 or 512 by 512 pixels (see video S3 in the supplemental material) were collected at 5-min time intervals. Multiple coordinates per treatment from the chamber wells were collected through a 20ϫ lens objective, magnified to ϫ30 with a ϫ1.5 magnifier, for an overall duration ranging from 20 to 40 h. Select time intervals were linked to generate MPEG movies using SoftWoRx software (Applied Precision, Inc.).
Cell synchronization by thymidine block. A double-thymidine block was used to synchronize HCT116 cells seeded in 10-cm plates at 1.5 ϫ 10 6 cells per plate and grown overnight as previously described (29) . After the second thymidine block, cells were washed and put into deoxycytidine medium; this process was designated as time zero. Samples were collected for flow cytometry, and RNA extraction was performed at 2-h intervals from time zero to 24 and 36 h.
Molecular profiling of synchronized HCT116. Cell lysates were homogenized using QIAshredder spin columns and total cellular RNA was isolated using the RNeasy mini kit (QIAGEN). RNA amplification, labeling, and hybridization to hu25K ink-jet DNA microarrays was carried out as previously described (10, 28) .
Cell cycle analysis. To analyze cell cycle profiles, approximately 1 ϫ 10 5 to 5 ϫ 10 5 cells were harvested along with their accompanying medium and pelleted by centrifugation in order to obtain both adherent and detached cells for subsequent analysis. Ethanol-fixed cells were prepared for flow cytometry as previously described (24) . For each sample, 10,000 events were collected using a FACS Calibur flow cytometer (Becton Dickinson) and incorporation of propidium iodide was used as a marker for DNA content. Aggregated cells were gated out, and cell cycle profiles were analyzed using FlowJo cytometry analysis software (version 4.0.2).
Expression and purification of recombinant KIF14 motor domain. A KIF14 gene fragment encoding amino acids V 342 through to K 720 was PCR amplified from cDNA clone KIAA0042 and cloned into pET22b (Novagen) using NdeI and XhoI sites engineered into the PCR primers. Escherichia coli BL21 (DE3) was transformed and cultured for 50 h at 18°C in LB broth containing 2 mM MgCl 2 and 50 g/ml carbenicillin. Harvested cells (20 g ) were suspended in buffer (20 mM Tris-Cl [pH 8.0], 300 mM NaCl, 0.1% Tween, 10 mM imidazole, 2 mM MgCl 2 , 5 mM ␤-mercaptoethanol) and lysed by French press. The sample was clarified and batch bound to 0.3 ml nickel-nitrilotriacetic acid (QIAGEN). Bound proteins were eluted by applying a step gradient of lysis buffer containing imidazole and analyzed by SDS-PAGE. Fractions were pooled, diluted 10-fold with cation exchange buffer (50 mM HEPES [pH 6.8], 1 mM MgCl 2 , 1 mM EDTA, 10 M ATP, 1 mM dithiothreitol), and applied to a 1.0-ml HiTrap SP HP (Amersham Biosciences). Protein was eluted with a linear gradient to 750 mM KCl and analyzed by SDS-PAGE. Pooled fractions were diluted with buffer to 200 mM KCl, concentrated in a Centricon-30 concentrator, and spiked with glycerol to 10% vol/vol for storage at Ϫ70°C.
ATPase activity assay. Taxol-stabilized microtubules were prepared as described previously (13) and stored at 20 M at room temperature. ATPase activity reactions (50 l) contained 50 mM (PIPES) piperazine-N,NЈ-bis(2-ethanesulfonic acid) (pH 7.0), 1 mM EGTA, 1 mM dithiothreitol, 100 g/ml bovine serum albumin, 2 mM MgCl2, 1 mM NaATP, 150 nM KIF14 motor domain, and differing amounts of taxol-stabilized microtubules. Reactions were incubated for 0 to 20 min at room temperature and quenched with 50 l stop solution (1.8 M KCl, 50 mM EDTA). Propidium iodide was detected by addition of Quinaldine Red-ammonium molybdate.
RESULTS
KIF14 contains an internally positioned N-type motor that exhibits microtubule-dependent ATPase activity. A defining characteristic of kinesin motor domains is their microtubuledependent ATPase activity. We assayed the ATPase activity of KIF14 in vitro by using recombinant KIF14 motor domain. As shown in Fig. 1A , the intrinsic ATPase activity of the KIF14 motor is enhanced upon the addition of taxol-stabilized microtubules. Notably, the internal location within the polypeptide of the KIF14 motor, 5-prime of four coiled-coil domains and a forkhead-associated domain as detailed in Fig. 1B , indicates an I-type classification for this kinesin. However, the KIF14 neck sequence is carboxy terminal and contains conserved plus-end- 1C ) (16) . KIF14 expression is elevated in mitotic cells. The annotation for KIF14 and its orthologs, although limited, is consistent with functions ascribed to mitotic kinesins (17, 21, 33) . As a first step in further defining KIF14 as a mitotic kinesin, we examined whether KIF14 expression is elevated during mitosis as has been reported for several known mitotic kinesins (1, 5, 31) . We used microarray profiling to analyze the expression of KIF14 mRNA in synchronized HCT116 cells ( Fig. 2A) . Since our human 25K gene chip contains probes corresponding to a number of mitotic and transport kinesins, we were able to compare the regulation of KIF14 expression to that of wellannotated kinesins. A double-thymidine block was used to synchronize HCT116 at the G 1 /S transition. Arrested cells were released by the removal of thymidine, and cells were harvested for microarray hybridization as described in Materials and Methods. In addition, cells were also collected for cell cycle analysis by flow cytometry in order to quantitate the percentage of cells at each stage of the cell cycle. As shown in Fig. 2A , KIF14 transcripts accumulated in cells progressing through G 2 /M and peak levels were achieved approximately 2 h after the detection of maximal DNA content. This cell cycle-dependent regulation more closely mirrored those of known mitotic kinesins CENPE and Rab6-KIFL than those of the nonmitotic kinesins KIF5A and KIF5B (Fig. 2B ). These findings demonstrate that KIF14 expression is regulated in a manner consistent with it acting as a mitotic kinesin.
Cellular localization of KIF14 during the cell cycle. Characterization of the intracellular localization of specific mitotic kinesins to centrosomes (2), centromeres (30) , and the midbody (5) have proven to be instrumental in deciphering where and how these kinesins function during mitosis. We therefore characterized the subcellular localization of both exogenously and endogenously expressed KIF14 throughout the cell cycle. Immunofluorescence microscopy was used to evaluate the localization of exogenously expressed KIF14-EGFP in 293T cells (Fig. 3A and B) and endogenous KIF14 in HeLa cells (Fig.  3C ). KIF14-EGFP localization was restricted to the cytoplasm of interphase cells, while entry into mitosis triggered a redistribution of KIF14-EGFP to the nucleus (Fig. 3A) . During prophase, KIF14 accumulated at the developing spindle poles and their associated microtubules; a similar distribution was observed in cells throughout metaphase (Fig. 3B and C) . In contrast, during anaphase, KIF14 accumulated at the spindle midzone, and appeared increasingly concentrated at the midbody during telophase (Fig. 3A through C) . In cells that were ready to undergo abscission, KIF14 was consolidated at the contractile ring (Fig. 3A through C) and colocalized with the midbody-associated proteins KNSL5, RhoA, and ECT2 (see Fig. S1 in the supplemental material). Distinct changes in ploidy are linked with KIF14 siRNA efficacy. The concentration of KIF14 at the midbody raised the possibility that, in addition to its reported role in regulating chromosome congression and alignment (33) , KIF14 might function during mammalian cell cytokinesis. Therefore, we expanded our examination of KIF14 function by using siRNAs to silence KIF14 in HeLa cells. Initial results suggested that different siRNAs elicited different phenotypes (unpublished data). To more firmly establish the cellular phenotypes resulting from KIF14 silencing, we evaluated several KIF14-specific siRNA duplexes. Total RNA isolated from cells 24 h posttransfection was analyzed using quantitative PCR, and only those siRNAs that reduced KIF14 mRNA levels by more than 50% (unpublished data) were selected for further study. Using these validated siRNAs, cell cycle profiles of HeLa cells at 72 h after transfection were generated and compared to those of HeLa controls transfected with a siRNA directed against luciferase (Fig. 4A) .
We observed two distinct ploidy phenotypes in HeLa cells in response to KIF14 silencing. Four of 11 validated siRNAs elicited an increase in hypoploid cells that was greatest by 3 days posttransfection (Fig. 4A) (unpublished data) . An increase in annexin V staining preceded the increase in hypoploid cells in response to the silencing of KIF14 with these siRNAs, confirming death by apoptosis (unpublished data). The remaining seven siRNAs induced a phenotype that was associated with an increase in cells exhibiting tetraploid (4N) and polyploid (more than 4N) DNA content (Fig. 4A ) (unpublished data) that was caused not by an increase in mitotic cells but by a marked accumulation of multinucleated cells (Fig. 4B and see Fig. S2 in the supplemental material) . Importantly, a comparison of protein knockdown generated with a representative set of KIF14 siRNAs allowed for the segregation of these two phenotypes based upon siRNA efficacy (Fig. 4C) . "Strong" (S) siRNAs that generated the robust depletion of KIF14 (80% or greater) were responsible for the induction of the hyperploid phenotype, while "moderate" (M) siRNAs that generated less severe KIF14 silencing (less than 50%) induced the hypoploid phenotype. These data clearly demonstrate that siRNA efficacy can be used to segregate distinct phenotypes associated with KIF14 depletion.
Time-lapse microscopy reveals multiple cell cycle defects associated with KIF14 silencing. Time-lapse microscopy was utilized to characterize the fate of HeLa cells transfected with either a strong or a moderate KIF14 siRNA. The single prominent phenotype associated with strong silencing of KIF14 was failure to complete cytokinesis. Cells transfected with strong siRNAs were able to segregate chromosomes, proceed through anaphase, initiate furrow formation, ingress the furrow and elongate the midbody in manners similar to those of luciferase siRNA controls ( Fig. 5 and 6 ; see Videos S1 and S2 in the supplemental material). However, midbody cleavage did not occur in KIF14-depleted cells, resulting in midbody collapse and binucleated cells (see Video S2 in the supplemental material). The only marked difference we observed between control and KIF14-depleted cells when staining for KIF14 was a significant reduction in the concentration of KIF14 at the midbody of late-stage mitotic cells (Fig. 5) . The inability of KIF14-depleted cells to complete cytokinesis is consistent with the increase in ploidy observed by both flow cytometry and microscopy ( Fig. 4B; see Fig. S2 in the supplemental material) . In addition, extensive endoreduplication was toxic to HeLa cells in long-term colony-forming assays as multinucleate cells were observed to undergo apoptosis after subsequent failed attempts at mitosis (unpublished data).
Moderate KIF14 siRNAs could be differentiated from stronger siRNAs by their inductions of multiple phenotypes. Whereas strong KIF14 siRNAs could induce several rounds of endoreduplication (see Video S3 in the supplemental material) prior to the induction of apoptosis, the most common phenotype associated with moderate KIF14 siRNAs was cytokinesis failure and binucleation followed by apoptosis that occurred after mitotic exit (Table 2 and Fig. 7A ; see Video S4 in the supplemental material). In addition to this binucleation fol- lowed by apoptosis phenotype, moderate KIF14 silencing was also observed to induce apoptosis of cells upon mitotic entry (Table 2 and Fig. 7B ; see Video S5 in the supplemental material) while attempting cytokinesis (Table 2 and Fig. 7C ; see Video S6 in the supplemental material) or during interphase after completion of cytokinesis (Table 2 and Fig. 7D ; see Video S7 in the supplemental material). Furthermore, the progression from prophase to telophase in cells transfected with either moderate or strong KIF14 siRNAs was similar to that of control cells and did not exceed 90 min ( Fig. 6 and 7 ; unpublished data). This is in contrast to the several-hours-long delay at the metaphase-to-anaphase transition reported to occur in response to esiRNA-mediated silencing of KIF14 (33) . Taken together, these data reveal a concentration-dependent requirement for KIF14 at distinct stages during the cell cycle.
DISCUSSION
The human genome contains 45 kinesins (16) , and the functional characterization of each member of this motor protein superfamily remains a challenge. In this report, we have demonstrated that the putative KIF14 motor domain exhibits microtubule-dependent ATPase activity in vitro, confirming that KIF14 is in fact a kinesin. Our data also establish that, like other mitotic kinesins (31), KIF14 gene expression is under cell cycle regulation as an elevation of KIF14 transcripts coincides with mitotic progression. In addition, we have demonstrated that KIF14 localizes to the cytoplasm of interphase cells and redistributes to the nucleus, where it associates with the developing spindle in early mitotic cells. Coincident with the progression of cells beyond anaphase, KIF14 accumulates at the midbody, becoming concentrated at the contractile ring prior to the completion of cytokinesis in a manner that mimics the subcellular localization of kinesins known to regulate cytokinesis (1, 5, 9, 15, 32) . We have determined that strong RNAimediated depletion of KIF14 can induce cytokinesis failure, FIG. 4 . Distinct changes in ploidy are linked with KIF14 siRNA efficacy. (A) HeLa cells transfected with KIF14-specific moderate and strong siRNAs, M-1, M2, S-1, S-2, and S-3, were analyzed by flow cytometry 72 h after transfection. The DNA content of KIF14-specific siRNAtransfected cells is compared to that of cells transfected with a luciferase-specific siRNA. (B) Cells transfected with either of two polyploid-inducing KIF14-specific siRNAs (S-1 or S-2) were analyzed by immunofluorescence microscopy at 72 h after transfection. Staining with ␣-tubulin and Hoechst allowed the evaluation of nuclear morphology of single cells. A total of 100 cells were evaluated for each siRNA duplex, and the number of mononuclear, multinuclear, and mitotic cells was compared to those of a luciferase (Luc) siRNA control. (C) HeLa cells were transfected with a panel of KIF14-specific siRNAs linked to different ploidy phenotypes as described in Fig. 4A . Cells were harvested 24 h after transfection, and equal amounts of protein were analyzed by immunoblotting with anti-KIF14 antibody. Cells transfected with an siRNA targeting luciferase, a gene not expressed in mammalian cells, served as the negative control. Those siRNAs that reduced KIF14 expression by less than 50% are labeled as moderate. Those siRNAs that reduced KIF14 expression more than 80% are labeled as strong. The percent of KIF14 remaining for each sample was calculated using Oct1 as a load control. ple points during mitosis and (ii) clearly define KIF14 as a mitotic kinesin whose function is essential for cytokinesis. In addition, these data demonstrate that with RNAi, it is possible to elicit distinct phenotypes over a range of gene expression levels. This is reminiscent of the use of short hairpin RNA to induce epiallelic hypomorphs of TP53 in mice (8) .
The effects of KIF14 silencing in HeLa cells that we observed differ from what was reported to occur in response to FIG. 6 . Strong silencing of KIF14 prevents midbody cleavage and induces cytokinesis failure. HeLa cells were transfected with either a luciferase-specific siRNA (A) or the S-1 KIF14-specific siRNA (B). Twenty hours posttransfection, time-lapse imaging was initiated and images were generated at 5 min intervals for 20 h. The elapsed time for each sequence of images is denoted in minutes with the initial image set at time (T) zero.
esiRNA-mediated silencing of KIF14 (33) . Specifically, an esiRNA pool targeting KIF14 was shown to disrupt chromosome congression and alignment, resulting in a prolonged delay at the metaphase-to-anaphase transition (33) . Moreover, this study did not report an increase in apoptosis or a defect in cytokinesis nor did a study that reported the absence of any mitotic phenotype in response to siRNA-mediated silencing of the KIF14 ortholog KLP38B in Drosophila S2 cells (7) . However, mutants in KLP38B have been linked with cytokinesis failure (21) and defects in chromosome segregation (17) . It is important to point out that, in the Drosophila S2 cell experiments, siRNA efficacy was not determined as experiments evaluating mRNA or protein knockdown were not reported (7) . Additionally, the mRNA silencing reported for the KIF14 esiRNA pool used by Zhu et al. was approximately 60%, moderate by our definition, but how this reduction in mRNA affected protein levels was not evaluated (33) . Furthermore, given the limitation that each siRNA duplex FIG. 7 . Moderate silencing of KIF14 induces apoptosis at multiple points in the cell cycle. HeLa cells were transfected with M-1 KIF14-specific siRNA and time-lapse imaging was initiated at 20 h posttransfection (A, B, and C) or 40 h posttransfection (D). Apoptosis can be seen to occur after failed cytokinesis and binucleation (A), prior to progression beyond metaphase (B), during an attempt at cytokinesis (C), and after completion of cytokinesis (D). Images were generated at 5 min intervals for 20 h, and for each sequence of images, the initial image is denoted as time (T) zero. a Time-lapse microscopy was utilized to determine the percentage of penetrance. HeLa cells were transfected with either a luciferase control siRNA or the moderate KIF14 siRNA M-1. Time-lapse was initiated 30 h posttransfection and was terminated 24 h later. The baseline level of apoptosis was determined by counting the number of apoptotic events that occurred within a population of 100 luciferase siRNA-transfected cells. For M-1 transfected cells, 75 apoptotic events were scored.
b All apoptotic events were segregated based upon the stage of the cell cycle where apoptosis occurred. exhibits a unique "off-target" gene expression profile when introduced into a cell (11), the validation of phenotypes obtained by using siRNA pools is best confirmed by reproducing the phenotype with multiple single siRNAs.
Our experiments do not confirm a role for KIF14 in chromosome congression and alignment as we did not observe the metaphase-to-anaphase delay described by Zhu et al. despite testing several KIF14 siRNAs with different efficacies. Importantly, we show by using multiple siRNAs that, in response to strong KIF14 silencing, HeLa cells progress unimpeded through mitosis and are able to initiate furrow formation and ingression. However, these cells were unable to cleave the intracellular bridge connecting the dividing cells, resulting in midbody collapse, cell fusion, and binucleation. Together, these data support a role for KIF14 during cell abscission.
In addition to cytokinesis failure, we observed an increase in cell death in response to moderate KIF14 silencing that is preceded by an increase in annexin V staining confirming death by apoptosis (unpublished data). Time-lapse microscopy revealed that cell death in response to moderate KIF14 silencing occurred at three distinct points: prior to anaphase, during cytokinesis, or after mitotic exit. It is difficult to speculate as to why moderate KIF14 silencing is able to trigger this acute apoptotic phenotype, while the predominant, immediate effect caused by strong KIF14 silencing is cytokinesis failure. One possibility is that KIF14 may indirectly, through some yet-tobe-defined cargo, serve to enable the function of a mitotic sensor able to elicit an apoptotic signal in response to mitotic spindle abnormalities. Such a sensor function could operate throughout mitosis and would be diminished or eliminated as a consequence of strong KIF14 silencing. Importantly, the link we observed between siRNA efficacy and phenotypic outcome indicates that different stages of the cell cycle can be disrupted by changing the level of KIF14 expression and this could explain the diversity of phenotypes reported for both KIF14 (33) (this report) and its Drosophila ortholog (21) (17) .
Our characterization of KIF14 as a mitotic kinesin may be functionally significant to its identification as a poor-prognosis breast cancer gene (28). Our data are consistent with the hypothesis that elevated expression of KIF14 serves as a reporter for highly proliferative cancers as increased proliferation has been shown to strongly correlate with poor-prognosis breast cancer (27) . Alternatively, the recent identification of KIF14 as a candidate oncogene (4) raises the interesting possibility that mitotic spindle or cytokinesis defects that might result from KIF14 overexpression could lead to increased genetic instability and progression towards aneuploidy in certain cell types or genetic backgrounds (6, 20) . It will be important to determine whether the elevated expression of KIF14 serves to promote oncogenesis, as this would warrant evaluation of KIF14 as a target for new antineoplastic compounds.
